NDC to RxNorm Crosswalk 62541-203 Qsymia

View RxNorm Concepts, RxCUIs, Term Types

RxNorm Crosswalk Information

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The RxNorm crosswalk for NDC code 62541-203 indicates multiple RxNorm Concept Unique Identifiers known as RxCUIs associated to the product Qsymia . The unique RxCUI concepts linked to this product are: 1302827, 1302833, 1302839, 1302845, 1302850, 1302856, 1313059 and 1313061. RxCUIs are identifiers that group each chemically distinct drug into a single code regardless of manufacturer or package size. Drugs mapped to the same RxCUI are considered the same drug as having the same ingredients, strengths, and dose forms. The RxNorm mapping may include repeated RxCUI concepts with different descriptions and term types.

RxCUI: 1302827

Concept: phentermine 7.5 MG / topiramate 46 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 24 HR phentermine 7.5 MG / topiramate 46 MG Extended Release Oral Capsule
Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form
Concept: phentermine 7.5 MG / topiramate 46 MG 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1302833

Concept: Qsymia 7.5 MG / 46 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 24 HR phentermine 7.5 MG / topiramate 46 MG Extended Release Oral Capsule [Qsymia]
Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
Concept: Qsymia 7.5/46 (phentermine (as hydrochloride) / topiramate) 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Qsymia 7.5/46 (phentermine / topiramate) 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Qsymia 7.5/46 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1302839

Concept: phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 24 HR phentermine 3.75 MG / topiramate 23 MG Extended Release Oral Capsule
Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form
Concept: phentermine 3.75 MG / topiramate 23 MG 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1302845

Concept: Qsymia 3.75 MG / 23 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 24 HR phentermine 3.75 MG / topiramate 23 MG Extended Release Oral Capsule [Qsymia]
Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
Concept: Qsymia 3.75/23 (phentermine (as hydrochloride) / topiramate) 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Qsymia 3.75/23 (phentermine / topiramate) 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Qsymia 3.75/23 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1302850

Concept: phentermine 15 MG / topiramate 92 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 24 HR phentermine 15 MG / topiramate 92 MG Extended Release Oral Capsule
Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form
Concept: phentermine 15 MG / topiramate 92 MG 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1302856

Concept: Qsymia 15 MG / 92 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 24 HR phentermine 15 MG / topiramate 92 MG Extended Release Oral Capsule [Qsymia]
Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
Concept: Qsymia 15/92 (phentermine (as hydrochloride) / topiramate) 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Qsymia 15/92 (phentermine / topiramate) 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Qsymia 15/92 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1313059

Concept: phentermine 11.25 MG / topiramate 69 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 24 HR phentermine 11.25 MG / topiramate 69 MG Extended Release Oral Capsule
Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form
Concept: phentermine 11.25 MG / topiramate 69 MG 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1313061

Concept: Qsymia 11.25 MG / 69 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 24 HR phentermine 11.25 MG / topiramate 69 MG Extended Release Oral Capsule [Qsymia]
Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
Concept: Qsymia 11.25/69 (phentermine (as hydrochloride) / topiramate) 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Qsymia 11.25/69 (phentermine / topiramate) 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Qsymia 11.25/69 (phentermine 11.25 MG / topiramate 69 MG) 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Qsymia 11.25/69 24 HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.


What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The goal of RxNorm is to facilitate the efficient exchange of drug information among the computer systems used by hospitals, pharmacies, clinics and other organizations. To achieve this goal RxNorm provides normalized names and unique identifiers for drugs and medicines.

What is an RXCUI?

An RxCUI is machine readable unique identifier that defines the same common concept. Every name and code provided to the National Library of Medicine receives an RXCUI. Drug products that map to the same RxCUI are considered the same drug while drugs that are distinct will have different RxCUIs.

What is a Term Type (TTY)?

Term Types (TTYs) are used to specify the level of complexity of each RxCUI term.

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.